Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 3

Conditions

Breast Neoplasms 4997Neoplasms 4192Prostatic Neoplasms 2426Carcinoma, Non-Small-Cell Lung 2261Colorectal Neoplasms 2050Lung Neoplasms 1703Multiple Myeloma 1454Lymphoma 1403Leukemia, Myeloid, Acute 1379Neoplasm Metastasis 1372Melanoma 1269Pancreatic Neoplasms 1200Leukemia 1194Ovarian Neoplasms 1190Lymphoma, Non-Hodgkin 1128Precursor Cell Lymphoblastic Leukemia-Lymphoma 1088Head and Neck Neoplasms 1055Leukemia, Lymphocytic, Chronic, B-Cell 994Lymphoma, Follicular 896Colonic Neoplasms 893Brain Neoplasms 875Stomach Neoplasms 854Recurrence 848Carcinoma, Hepatocellular 845Glioblastoma 837Lymphoma, Large B-Cell, Diffuse 770Rectal Neoplasms 758Uterine Cervical Neoplasms 725Carcinoma, Renal Cell 704Hodgkin Disease 696

Interventions

Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Ovarian Epithelial Cancer Recurrent × Clear all
NCT02735928 2023-11-15

PARROT

Catholic University of the Sacred Heart

Phase NA Completed
40 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

NCT02260544 2016-09-23

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection

Dr. Reddy's Laboratories Limited

Phase 1 Completed
49 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

NCT02026921 2014-01-03

A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Phase 2 Completed
74 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡